Success Stories: EB-1A Approved for a Postdoctoral Research Associate in Missouri in the Field of Medical Biochemistry

On February 13th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Research Associate in the Field of Medical Biochemistry (Approval Notice)


General Field: Medical Biochemistry

Position at the Time of Case Filing: Postdoctoral Research Associate

Country of Origin: c

Service Center: Nebraska Service Center (NSC)

State of Residence at the Time of Filing: Missouri

Approval Notice Date:  February 13th, 2015

Processing Time: 23 days (8 days after Requesting Premium Processing)

 

 


Case Summary:

Our client in this case was a medical biochemist from India who had made numerous findings in neurodegeneration and the pathogenesis of neurodegenerative diseases.  His work had resulted in 12 peer-reviewed scientific articles, 1 book chapter, and numerous presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 425 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work.  He had also reviewed 8 manuscripts for 7 distinctive, internationally-circulated journals. An independent recommender remarked upon his superior expertise: “[Client’s] research is also very well-regarded and has received a large amount of attention, demonstrated by his citation count. Moreover, he has also been sought after for peer reviews, once again indicating his good standing in the scientific arena.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Medical Biochemistry, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 23 days (8 days after requesting Premium Processing).